We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Novacyt, Cepheid Signs Strategic Alliance

News   Oct 05, 2016

 
Novacyt, Cepheid Signs Strategic Alliance
 
 
Advertisement
 

RELATED ARTICLES

Growth Factor R-spondin Suppresses Colorectal Cancer Growth

News

R-spondin, which enhances the growth of normal cells in the gut, suppresses the growth of intestinal cancer cells, thus reducing the formation of intestinal tumors, according to a new study.

READ MORE

A Cheaper, Faster COVID-19 Test Developed

News

Researchers at Karolinska Institutet have developed a method for fast, cheap, yet accurate testing for COVID-19 infection. The method simplifies and frees the testing from expensive reaction steps, enabling upscaling of the diagnostics.

READ MORE

$111 Million NIH Grant Awarded To Combat HIV-Associated Cancers

News

For 25 years, the AIDS Malignancy Consortium (AMC) has led national and international efforts to prevent and treat of HIV-related cancers. Now, Montefiore Health System and Albert Einstein College of Medicine have received a five-year, $111 million grant from the National Cancer Institute (NCI) to lead this research consortium.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE